BioSpace News Archive

F-star Therapeutics, Inc. announced that the United States Patent and Trademark Office has granted the Company a patent protecting the composition of matter of F-star’s SB 11285, a second generation STING agonist.

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the second of two Phase 3 (ESSENCE-2) studies, evaluating the investigational drug CyclASol® to treat the signs and symptoms of dry eye disease DED, has been completely enrolled with a total of 834 participants.

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present an overview of the Company at the H.C. Wainwright Ophthalmology Virtual Conference on Tuesday, August 17, 2021.

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today highlighted presentations at the upcoming 2021 Society of Neuro-Oncology (SNO) Conference on Brain Metastases, to be held in a virtual format from August 19 to 20, 2021.

Prolacta Bioscience is proud to announce the company’s senior director of advocacy and government affairs, Carolyn TenEyck, RN, was honored with the Lifetime Achievement Award from the National Black Nurses Association (NBNA) for her remarkable contributions to improving the lives of numerous patient groups over the last 20 years, including premature and critically ill infants.